Page last updated: 2024-11-04

sevoflurane and Xeroderma Pigmentosum

sevoflurane has been researched along with Xeroderma Pigmentosum in 2 studies

Sevoflurane: A non-explosive inhalation anesthetic used in the induction and maintenance of general anesthesia. It does not cause respiratory irritation and may also prevent PLATELET AGGREGATION.
sevoflurane : An ether compound having fluoromethyl and 1,1,1,3,3,3-hexafluoroisopropyl as the two alkyl groups.

Xeroderma Pigmentosum: A rare, pigmentary, and atrophic autosomal recessive disease. It is manifested as an extreme photosensitivity to ULTRAVIOLET RAYS as the result of a deficiency in the enzyme that permits excisional repair of ultraviolet-damaged DNA.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zarrouki, Y1
Makoudi, M1
Ziadi, A1
Elamrani, D1
Ettalbi, S1
Samkaoui, MA1
Brunner, T1
Jöhr, M1

Other Studies

2 other studies available for sevoflurane and Xeroderma Pigmentosum

ArticleYear
Anesthesia for patients with xeroderma pigmentosum: A twelve consecutive patients case series.
    Journal of clinical anesthesia, 2017, Volume: 42

    Topics: Adolescent; Adult; Amoxicillin-Potassium Clavulanate Combination; Androstanols; Anemia; Anesthesia;

2017
Anesthetic management of a child with xeroderma pigmentosum.
    Paediatric anaesthesia, 2004, Volume: 14, Issue:8

    Topics: Anesthesia, General; Anesthetics, Inhalation; Anesthetics, Intravenous; Cheek; Child; Female; Fentan

2004